ArticleCNS neuroscience & therapeutics2025
Development and Validation of Multiple Machine Learning Models Integrating Neutrophil-Lymphocyte Ratio for Prediction of Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke.
Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Low atherogenic index of plasma is associated with spontaneous hemorrhagic transformation in acute ischemic stroke patients: a retrospective cohort study and predictive modeling based on machine learning.Lipids in health and disease · 2026Article
- Associations of Different Inflammatory Markers with Neurological Deficit Severity and Short-Term Prognosis in Young Patients with Ischemic Stroke.Journal of inflammation research · 2026Article
- Comment on: "The Predictive Value of NLR, PLR, LMR, NPAR and D-Dimer on the Efficacy and Prognosis of First-Line Immunotherapy for Extensive-Stage Small Cell Lung Cancer" [Letter].Journal of inflammation research · 2026Article
- Early Identification of Endometrial Malignancy in Postmenopausal Women with Asymptomatic Endometrial Thickening: A Novel Explainable Machine Learning Model.International journal of medical sciences · 2026Article
- Development and Validation of Multiple Machine Learning Models Integrating Neutrophil-Lymphocyte Ratio for Prediction of Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke.CNS neuroscience & therapeutics · 2025Article
- Predicting intravenous thrombolysis outcomes in acute ischemic stroke using machine learning.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHemorrhagic transformation (HT) is a critical complication of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). This study developed and validated machine learning (ML) models integrating inflammatory biomarkers with clinical indicators to predict post-IVT HT.
methodsIn 1272 IVT-treated AIS patients, the least absolute shrinkage and selection operator (LASSO) regression identified five predictors from 17 variables, which were subsequently utilized to construct eight ML models. The models were trained (70% data) and tested (30% data). Furthermore, external validation conducted on an independent cohort substantiated the generalizability of the optimal model. The SHapley Additive exPlanations (SHAP) method explained feature importance.
resultsLASSO screened five significant predictors: the neutrophil-to-lymphocyte ratio (NLR), admission National Institutes of Health Stroke Scale (NIHSS) score, the Alberta Stroke Program Early CT Score (ASPECTS), blood glucose, and atrial fibrillation. Logistic regression (LR) achieved optimal performance with an AUC of 0.833 internally and 0.842 externally. SHAP analysis prioritized NIHSS as the top contributor, while the nomogram elucidated the variability in HT risk.
conclusionIntegrating NLR with stroke severity and neuroimaging biomarkers enhances the accuracy of HT predictions. The LR-based nomogram provided a practical tool for personalized IVT decisions, emphasizing the prognostic value of systemic inflammation in AIS management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.